In older adults, use of a recombinant zoster vaccine was associated with Guillain-Barré syndrome
- PMID: 35226533
- DOI: 10.7326/J22-0010
In older adults, use of a recombinant zoster vaccine was associated with Guillain-Barré syndrome
Abstract
Goud R, Lufkin B, Duffy J, et al. Risk of Guillain-Barré syndrome following recombinant zoster vaccine in Medicare beneficiaries. JAMA Intern Med. 2021;181:1623-30. 34724025.
Comment on
-
Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.JAMA Intern Med. 2021 Dec 1;181(12):1623-1630. doi: 10.1001/jamainternmed.2021.6227. JAMA Intern Med. 2021. PMID: 34724025 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical